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ABSTRACT 
Telomeres are a cornerstone when it comes to protecting coding DNA in chromosomes. 
They consist of tandem repeats of a sequence of 6 nucleotides: (TTAGGG)n for humans. 
Their protective function prevents the ends of linear chromosomes from being 
recognized as damaged DNA and activate repair processes. However, telomeres slightly 
shorten every cell cycle due to the inability of DNA polymerase to replicate linear DNA 
completely. This fact limits the lifespan of cells. 
Some types of cells such as germ cells cannot afford this loss and have telomerase 
activity, the enzyme responsible to lengthen telomeres by adding telomeric sequences 
to one of the strands of DNA. 
Telomeres are involved in aging process as well as in some age-related diseases such as 
diabetes or cancer. Apart from hereditary factors, there are also a great number of non-
genetic external factors that can aggravate telomere shortening. Thus, the probability 
of suffering illness or even premature death is increased. 
This project reviews the structure and function of telomeres, as well as the action 
mechanism of telomerase, to better understand how they take part in certain diseases 
afterwards. 
 
RESUM 
Els telòmers són una peça clau quan es tracta de protegir l’ADN codificant dels 
cromosomes. Estan formats per repeticions en tàndem d’una seqüència de 6 nucleòtids: 
(TTAGGG)n en el cas dels humans. La seva funció protectora evita que els acabaments 
dels cromosomes lineals siguin reconeguts com a ADN danyat i s’activin processos de 
reparació. No obstant, en cada cicle cel·lular els telòmers s’escurcen una mica degut a 
la impossibilitat de l’ADN polimerasa per replicar completament ADN lineal. D’aquesta 
manera queda limitada l’esperança de vida cel·lular. 
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Alguns tipus de cèl·lules com les germinals no poden permetre’s aquesta pèrdua i tenen 
actiu l’enzim telomerasa, encarregat d’allargar els telòmers afegint seqüències 
telomèriques en una de les dues cadenes de l’ADN. 
Els telòmers estan involucrats en el procés d’envelliment, així com amb l’aparició de 
diverses malalties relacionades amb l’envelliment, com ara la diabetis o el càncer. A part 
dels factors hereditaris, també hi ha un seguit de factors externs no genètics que poden 
agreujar la pèrdua de telòmers, augmentant així la probabilitat de sofrir malalties o fins 
i tot una mort prematura. 
En aquest treball es revisa l’estructura i funció dels telòmers, així com el mecanisme 
d’acció de la telomerasa per, posteriorment, entendre millor com estan involucrats en 
certes malalties. 
 
RESUMEN 
Los telómeros son una pieza clave cuando se trata de proteger el ADN codificante de los 
cromosomas. Están formados por repeticiones en tándem de una secuencia de 6 
nucleótidos: (TTAGGG)n en el caso de los humanos. Su función protectora evita que las 
puntas de los cromosomas lineales sean reconocidas como ADN dañado y se activen 
procesos de reparación. No obstante, en cada ciclo celular, los telómeros se acotan un 
poco debido a la imposibilidad de la ADN polimerasa para replicar completamente ADN 
lineal. De esta forma queda limitada la esperanza de vida celular. 
Algunos tipos de células como las germinales no pueden permitirse esta pérdida y tienen 
la enzima telomerasa activa, encargada de alargar los telómeros añadiendo secuencias 
teloméricas en una de las dos cadenas del ADN. 
Los telómeros están involucrados en el proceso de envejecimiento, así como con la 
aparición de diversas enfermedades relacionadas con el envejecimiento, como la 
diabetes o el cáncer. Además de los factores hereditarios, también hay una serie de 
factores externos no genéticos que pueden agravar la pérdida de telómeros, 
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aumentando así la probabilidad de sufrir enfermedades o incluso una muerte 
prematura. 
En este trabajo se revisa la estructura y función de los telómeros, así como el mecanismo 
de acción de la telomerasa para, posteriormente, entender mejor cómo están 
involucrados en ciertas enfermedades. 
 
INTEGRATION OF THE DIFFERENT FIELDS 
A great part of this project deals with the structure of chromosomes’ ends, the DNA 
sequence and telomerase enzyme as well as the functioning of it, so the main scope of 
this project is Biochemistry and Molecular Biology. 
The other two scopes related to this project in a more minority way are Physiology and 
Physiopathology and Public Health. The first one is referred to the age-related diseases 
where some illnesses are briefly described, while the second one is mentioned at the 
end, when lifestyle factors are explained to have a negative effect on telomere loss. 
These non-genetic factors can be reduced or even avoided if people are aware of them, 
and it is under Public Health’s power to make society be concerned. 
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1. INTRODUCTION 
Telomeres were first noticed by Herman Müller in 1938 while analysing chromosomal 
anomalies in the fly Drosophila induced by X-rays. He discovered that natural ends of 
chromosomes were never involved in reorganizations, fusions or translocations (1). 
Three years later, in 1941, Barbara McClintock was analysing the chromosomes in the 
plant Zea mays and figured out that during mitosis, a structure called anaphase bridge 
was formed. The tension between the two centromeres caused the breakage of the 
bridge, leading the ends of the chromosomes to fusion. McClintock found that the 
natural ends of chromosomes never cooperated with these fusions (2). So, in conclusion, 
both scientists deduced that the natural ends of chromosomes must have a special 
structure that prevent them from participating in such processes. 
It was not until the 1970s when telomeres became of interest again with Elisabeth 
Blackburn and Joseph G. Gall’s research group at Yale University. They sequenced the 
ends of linear mini-chromosomes in the protozoan Tetrahymena thermophile and, in 
1978, they published the results showing that telomeres were made up of G-rich DNA 
repeated sequences (TTGGGG)n (3). From then on, the telomeres of many different 
species have been described and apparently, these sequences are greatly conserved. 
A telomere is a section of DNA located at the end of a linear chromosome. They are a 
cornerstone when it comes to protection as they confer stability to chromosomes, 
prevent coding DNA from degradation, end-to-end fusions or fraying usually observed 
in damaged DNA, either by X-rays or physical fracture (4). 
A human repetitive DNA library was constructed from randomly sheared and 
reassociated DNA and it was then screened with 32P-labeled human repetitive DNA (5). 
Two of the clones used contained copies of tandem arrays of the hexadeoxynucleotide 
sequence (TTAGGG)n. Unlike other tandem repetitive patterns which are distributed in 
different chromosomes, this sequence was present on each human chromosome 
regardless of chromosome length. The estimated quantity of (TTAGGG)n sequences in 
the human genome was 3,000 – 12,000 base pairs per chromosome. 
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1.1. Telomeres’ structure 
Like most DNA of the chromosomes, telomeres are constituted by a DNA double-strand 
of this short sequence rich in G-C deoxynucleotides and a 3’ single-strand overhang, the 
one that contains guanines. 
At the beginning, it was thought that telomeres were linear structures, but some 
investigations demonstrated that it formed a loop due to two telomeric repeat-binding 
factors, TRF1 and TRF2 (6). These studies showed how, when inhibiting TRF2, the DNA 
damage checkpoint pathway was activated. Thus, a possible way to form this structure 
was supposed (Figure 1). It was proposed that TRF1 created a loop-back structure – the 
T-loop (telomere’s loop) – and TRF2 kept it tightly joined by the insertion of the 3’ 
overhang into the double-strand DNA, which led to a triple strand called D-loop or 
displacement loop (7,8). This was the origin of the capping function of telomeres and 
how they protect themselves from being recognised as damaged DNA. 
Nowadays, more telomere-associated proteins are known. In human being, the 
protective complex or shelterin protein complex is composed of six proteins: TRF1, TRF2, 
Figure 1: Proposed structure, formation and function of T loops. Figure adapted from ref. (6). 
(A) The DNA structure at the ends of mammalian chromosomes and a description of the 
proposed configuration of t loops. 
(B) Speculative scheme depicting a possible mode of t loop formation based on the in vitro 
biochemical activities of TRF1 and TRF2. T loops are proposed to mask telomere 
termini from cellular activities that can act on DNA ends. 
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RAP1, TIN2, TPP1 and POT1 (9). They interact with each other to stabilize the loop 
structure (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
TRF1, TRF2 attach specifically straight to telomeric DNA duplex and POT1 binds only to 
the 3’ strand, either it is double-stranded or the displaced overhang forming the D-loop 
(9–12). TIN2 acts as a bridge between TRF1 and TRF2 and TPP1 binds both POT1 and 
TIN2. The amino terminus of TPP1 incorporates a domain related to the recruitment of 
telomerase (13). RAP1 is associated with TRF2 and even though it is not essential for the 
capping function, recently studies showed that it impedes telomere recombination and 
delicacy (14,15). 
The protective complex not only avoids the activation of DNA repair processes but it is 
also involved in the regulation of the enzyme responsible for the extension of telomeres 
(16). 
Figure 2: Structure of telomeres and the shelterin complex. Figure adapted from 
ref. (16). 
(A) Model of the telomere’s structure with the T-loop and the D-loop. 
(B) Representation of the different proteins forming the shelterin 
complex. 
TRF 1 and 2: telomeric repeat binding factor 1 and 2            POT1: protection of telomeres 1 
TIN2: TRF-1 interacting protein 2               TPP1                 RAP1: repressor/activator protein 1            
Telomeres and the aging process                                                                   Sandra Matas Fernández 
8 
 
1.2. The end-replication problem 
Every time a cell divides, it first replicates the 
genome with a DNA polymerase but the 
properties of this enzyme make it impossible to 
entirely copy the linear DNA molecules out to the 
extreme by the normal process (17,18). The 
requisite for a primer to start the synthesis and 
the unidirectional growth of the new strand 
cause the known as “end-replication problem”. 
DNA polymerase can only synthesize DNA in the 
5’ to 3’ direction and it also needs an RNA primer 
with a free 3’-OH group. 
Since DNA is formed with two anti-parallel 
strands, when a bubble of replication is created, 
the leading strand is synthesized without 
interruption in the same direction as the 
replication fork moves forward. However, the 
lagging strand is synthesized in the opposite 
direction discontinuously using more RNA 
primers (Okazaki fragments) (Figure 4). These 
primers are then eliminated and replaced by 
DNA, but the removal of the 5’-end primer will 
imply a loss of a small part of the telomere, as 
DNA polymerase will not have any 3’-OH group to 
start from. Furthermore, if the overhang is not 
long enough, there is an extra deterioration of 
the telomeres to ensure the t-loop can be 
formed. As a result, telomeres shorten between 50 and 200 base pairs after each 
replication cycle (Figure 3), but this is exactly why they are designed for, so that 
proliferation can take place without losing important genetic information or functions. 
Considering that, telomeres delimit the number of times a cell can divide. 
Figure 3: Explanation of the end-replication 
problem. Figure adapted from ref. (87). 
Telomeres and the aging process                                                                   Sandra Matas Fernández 
9 
 
This problem must be solved at least in 
germinal cells in order to transfer the 
complete genome through generations. It 
was seen that sperm has longer 
telomeres than somatic cells (19).  
Diverse organisms have acquired 
different methods to avoid DNA loss in 
their chromosome ends. Although most 
mammalians use a specific enzyme called 
telomerase, some human cells with 
telomerase inactivated can also maintain or extend their telomeres by alternative 
lengthening of telomeres (ALT), which consists in copying DNA sequences from one 
telomere to another (20). This mechanism would imply homologue recombination. 
 
1.3. Telomerase, the solution for the end-replication problem 
1.3.1. Structure of telomerase 
Telomerase was first discovered by Carol Greider and Elizabeth Blackburn in the ciliate 
Tetrahymena thermophile in 1985 (21), some years after Blackburn had sequenced its 
telomeres. This enzyme is a ribonucleoprotein (RNP), that is an RNA-dependent DNA 
polymerase which adds telomeric DNA sequences onto chromosome ends. Even though 
Tetrahymena’s telomerase is monomeric, 
the human telomerase is dimeric and has 
two main components: an RNA template for 
the synthesis called hTR or hTERC (22) and a 
catalytic protein with reverse transcriptase 
activity known as hTERT (23–25). There are 
also some associated proteins: dyskerin, 
NHP2, NOP10, Pontin / Reptin, GAR1 and 
TCAB1 (Figure 5). 
Figure 4: The replication fork. Figure from ref. (88). 
Figure 5. Schematic representation of telomerase 
and its associated proteins. Figure from ref. (89). 
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Figure 6. Proposed secondary structure of human telomerase RNA 
(hTR) subunits. The interaction of hTERT with hTR domains is 
indicated in grey dotted lines. Figure adapted from ref. (90). 
The heterotrimeric complex formed by dyskerin, NHP2 and NOP10 is essential for the 
stability of hTR in vivo (26). The association of this complex and GAR1 to hTR make the 
enzyme functional. Reptin and Pontin are two ATPases also needed to stabilize dyskerin 
and hTR in vivo. They interact with TERT, regulating it during the S phase of the cell cycle. 
The protein TCAB1 seems to regulate the subcellular location of telomerase (27).  
RNA template 
The phylogenetic comparative analysis of vertebrate TR showed three conserved 
domains: the CR4/CR5 domain, the pseudoknot/template core domain and a box H/ACA 
domain, each one with different functions (28) (Figure 6). 
The box H/ACA domain is necessary for TR stability, nuclear location, processing and 
telomerase activity in vivo. The pseudoknot domain is also needed for telomerase to 
work properly, as well as the CR4/CR5 domain although this is not fundamental for TR 
stability (29). These two last referred regions interact independently with hTERT. 
 
 
 
 
 
 
 
 
 
Catalytic subunit hTERT 
hTERT is a quite large protein with four main elements: the telomerase essential N-
terminal (TEN) domain, the telomerase RNA-binding (TRB) domain, the reverse 
transcriptase (RT) domain and the C-terminal extension (CTE) (30) (Figure 7). 
Telomeres and the aging process                                                                   Sandra Matas Fernández 
11 
 
The TEN domain contains the DAT (dissociates activities of telomerase) region, where 
mutations in this area stop telomere lengthening in vivo but do not affect the catalytic 
activity in vitro (31,32). TEN is therefore a key point to assemble telomerase to 
telomeres, as it has affinity for single-stranded telomeric DNA. 
The TRB domain has some conserved RNA binding sequences one of which is required 
to place hTR inside the active site of hTERT, specifically the telomerase-specific T motif 
with the CR4/5 region of hTR. 
The RT domain is considered the catalytic heart of the enzyme and it includes some 
conserved reverse transcriptase motifs (33). 
The CTE domain, similarly to TEN domain, is indispensable for in vivo lengthening of 
telomeres but it is not a requisite for in vitro activity of telomerase (34). 
 
 
 
 
 
 
1.3.2. Elongation of telomeres by telomerase 
Telomeres are known to exist in two different configurations. The “closed” state hides 
the 3’ overhang forming the T- and D- loops, preventing it from telomerase activity. The 
“open” conformation is the linear structure of telomeres, allowing the interaction with 
telomerase (35). 
Since human telomerase is dimeric, it is able to extend two telomere ends in parallel, in 
order that sister chromatids can maintain the same telomere length (36). 
Being in the open state, the lengthening of telomeres is accomplished within three steps 
(37,38): 
Figure 7. Structure of human telomerase reverse transcriptase (hTERT), 
the four key domains and some of their regions. Figure adapted from 
ref. (30). 
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Figure 8. Telomerase at work solving the DNA end replication problem. The enzyme telomerase consists 
of a protein and a short stretch of RNA that is complementary to the sequence at the overhanging 3’ end 
of telomeres. The telomerase activity is able to synthesize DNA from the RNA template whereupon the 
telomerase moves on, a step that is repeated several times. Then, the missing stretch can be filled in 5’ 
 3’ direction. Figure from ref. (91). 
 1- Substrate recognition and binding: telomerase attaches to the terminal end of 
the telomere and the nucleotides from the 3’ overhang are positioned in hTERT, 
aligning and hybridizing with the RNA template of hTR. 
 2- Elongation: a telomeric DNA repeat is synthesized by reverse transcriptase 
action, adding nucleotides complementary to the RNA template, so the overhang 
becomes longer. 
 3- Translocation or dissociation: telomerase is translocated to restart again the 
cycle, and when finished, it finally dissociates. 
Lastly, the 5’ end is completed by the conventional replication method with DNA 
polymerase. 
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Telomerase is a highly regulated enzyme in normal human cells. During embryonic 
differentiation it is repressed in most somatic cells except from some tissues, such as 
activated lymphocytes, gametes and stem cells (39,40). 
When normal mammalian somatic cells are cultured in vitro, they proliferate a limited 
number of times. The maximum possible number of divisions is known as the Hayflick 
limit (41). At that point, very short telomeres provoke a permanent growth arrest called 
replicative senescence or mortality stage 1 (M1) (42–44). If any cell cycle checkpoint 
gene as p53 is inactivated, cells can escape from senescence and continue dividing. If 
this occurs, telomeres are shortened even more and the cell reaches a second 
proliferative block or mortality stage 2 (M2) (45–47) where telomeres become 
dysfunctional and there is massive cell death. Very rare cells that evade M2 are able to 
activate telomerase leading to cellular immortalization (Figure 9). 
 
Figure 9. Two-step hypothesis of cellular senescence and immortalization. Unlike germ cells, in 
which telomere length is maintained by telomerase, most human somatic cells have lower levels 
of telomerase or are telomerase negative and experience telomere shortening with each cell 
division. Pluripotent stem cells are telomerase positive but do not maintain full telomere length. 
Telomere length shortens in stem cells at rates slower than that of telomerase-negative somatic 
cells. Critically shortened telomeres may signal cells to enter senescence at the Hayflick limit, or 
M1. This proliferative checkpoint can be overcome by inactivation of pRB/p16 or p53. Such cells 
continue to suffer telomere erosion and ultimately enter crisis, or M2, characterized by widespread 
cell death. Rare surviving cells acquire unlimited proliferative potential and stabilization of 
telomere length, almost universally by activation of telomerase. When cells are cultured in 
adequate conditions, ectopic expression of hTERT allows cells to bypass proliferation barriers and 
become immortal. Figure from ref. (92). 
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2. AIMS 
After research on telomeres and telomerase came to light to most science-unaware 
people by winning a Nobel prize, it caught my attention and became of my interest with 
the aim of learning a little bit more. 
The objectives of this project are the followings: 
 To review telomeres’ structure and their functions. 
 To analyse the structure of telomerase, the enzyme responsible for maintaining 
telomeres’ length, and how it works. 
 To study how telomeres and telomerase are involved in aging and age-related 
diseases. 
 
3. MATERIALS AND METHODS 
The methodology of this work has been based in a thorough bibliographic search and 
the subsequent synthesis of the articles found. 
The first general idea of telomeres and telomerase was obtained from Biochemistry 
books from the library of the university, but then, deeply investigation was done through 
data bases on internet. 
The main source of information has been PubMed, through the website 
www.ncbi.nlm.nih.gov/pubmed. Both full articles and reviews have been used, either 
searching general words as “structure of telomeres” or concrete papers using advanced 
research. I have used publications from a wide variety of journals such as Cell or Science. 
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4. RESULTS 
4.1. Telomere loss with aging 
The aging process is generally known by external visible evidences in humans such as 
skin wrinkling and spotting or hair greying. However, cellular aging is implicated behind 
these signs and it is related to telomere shortening throughout humans’ life. Because of 
the end-replication problem and lack of telomerase activity in most human cells, 
telomere loss with aging is unavoidable. A review of telomere shortening in different 
human tissues was carried out (Table 1) (48). 
Table 1. Yearly reduction rates of telomere length in human tissues. 
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Mean telomere length of neonates for cerebral cortex and liver were 13.1 ± 1.1 and 13.7 
± 2.2 kbp respectively (49) and those for subjects less than 10 years old (neonates 
included) were 13.1 ± 1.8 and 13.6 ± 2.3 kbp, which do not almost vary. The respective 
values for centenarians were 13.1 ± 2.3 and 8.7 ± 1.4 kbp. The mean telomere length for 
centenarians in these and other tissues were not shorter than 6 kbp, so in that point was 
considered to be the mortality stage 1 (48). 
All this data was obtained based on one unique tissue in several people but, when 
different tissues from one individual are observed, “it was suggested that when longer 
telomeres are shown in any particular organ in a given individual, the other organs will 
also have longer telomeres” (48). 
 
4.2. Telomeres and age-related diseases 
Apart from working as a biological clock, telomere shortening is also related to several 
age-related diseases to which elder people are more sensitive. 
4.2.1. Cancer 
When telomeres are not long enough, chromosomal instability is induced leading to 
cancer initiation (50). In addition, cancer cells show a high telomerase activity (51) 
despite normal somatic cells do not have this enzyme active. Approximately 85% - 90% 
of human cancers have detectable telomerase activity (39). The molecular mechanism 
for this activation is still unclear, but it is due to the necessity of telomere stabilization 
for tumour progression (52). Henceforth, some investigators came up with studies 
inhibiting telomerase activity in those kind of cancer, and the results showed cell death 
and tumour growth inhibition (53–56). 
Trying to extend lifespan in mice, telomerase was activated by constitutive over-
expression of TERT in different tissues. The result was a lifespan up to 10% longer 
compared to wild-type mice (57). On one hand, this increased life expectancy showed a 
low rate of age-related diseases but on the other hand, both induced and spontaneous 
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tumours were also induced in higher incidence, what caused mortality in the first year 
of life (57). 
4.2.2. Cardiovascular diseases 
Atherosclerosis and heart failure are aging-related diseases and frequently can cause 
the death. The areas of arterial wall with higher haemodynamic stress are more 
susceptible to atherosclerosis. This stress is believed to result in a more rapid cell 
turnover and shorter telomeres (58). 
People with short telomeres are more probable to develop hypertension even being 
healthy, and once they are hypertensive, with shorter telomeres are more vulnerable to 
suffer from atherosclerosis (59). 
4.2.3. Diabetes 
Type 2 diabetes is significantly associated with short telomeres and it could be ascribed 
in part to the oxidative stress that suffer these patients (60,61). A study revealed that 
subjects with atherosclerosis and type 2 diabetes have shorter telomeres than those 
with only diabetes (62). 
Type 2 diabetes is characterised by peripheral insulin resistance and β-cell dysfunction. 
It was seen that young adult mice with low telomerase activity expressed impaired 
glucose tolerance, which means that short telomeres can be responsible for 
dysfunctional replicative capacity of pancreatic β-cells (63). 
In addition, short telomeres can predict all the causes of mortality in the patients with 
type 1 diabetes (64). 
4.2.4. Immune system diseases 
The immune system needs a great telomere maintenance as it is a very dynamic cellular 
system. The rapid expansion of clonal T- and B-cell populations is the key point to be a 
competent immune system, and short telomeres can cause defective immune responses 
in old people (65). 
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Telomere loss is considered one of the greatest factors affecting morbidity and mortality 
(66). The most harmful effect on the elderly is the decline in T-cell action despite both 
the innate and adaptive immune responses are debilitated in old people (67). 
Moreover, people with short telomeres are eight times more likely to die of infectious 
diseases than people with long telomeres (68). 
4.2.5. Dyskeratosis congenital 
Some human diseases related to short telomeres are caused by genetic causes such as 
mutations in the DNA repair system or defective telomeres, and dyskeratosis congenital 
(DC) is one of them (69). If the mutations are in the RNA component of telomerase, it is 
autosomal dominant DC, while mutations in the gene encoding dyskerin protein are 
caused by X-linked DC (70). 
Patients with DC show premature aging signs such as grey hair, alopecia, tooth loss, 
defective skin pigmentation, osteoporosis and deterioration of the immune system. 
 
4.3. Impact of lifestyle factors on telomeres and aging 
It is well known to everyone that some lifestyle factors may negatively affect human 
health, and accelerated telomere loss is one of these consequences. 
4.3.1. Smoking 
Smoking accelerates telomere shortening and moreover, it seems to be a relation 
between the number of smoked cigarettes and the speed of telomere loss, meaning that 
telomere shortening and smoking are dose-dependent (71). 
A study was carried out in white blood cells of women and the results showed that the 
average rate of telomeric DNA loss was “25.7 – 27.7 base pairs” per year but, if a pack 
of cigarettes is smoked daily, 5 base pairs are additionally lost (72). As a consequence, 
the erosion of telomeres by daily smoking of one pack of cigarettes for a 40-year period 
is comparable to 7.4 years of life (72). 
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Some other authors have proposed that telomere length may predict the rate of aging 
by using it as a biomarker of the oxidative damage caused by smoking, although this 
oxidative stress can be prevented by antioxidant therapy (73). 
4.3.2. Obesity 
Since the waist circumference and BMI are related to high levels of reactive oxygen 
species in plasma and urine, obesity correlates with an increase of oxidative stress (74). 
In case of lean women, their telomeres are significantly longer than those in obese 
women of the same age group (72). 
Given that accelerated telomere loss in obese people equate to 8.8 years of life, it seems 
that obesity has a worse impact on telomere length than smoking (75). 
4.3.3. Environment 
The exposure to harmful agents of the environment may affect telomeres. Telomere 
length in leukocytes was evaluated by some researchers both from traffic police officers 
and office workers (76). The pollution was measured by levels of benzene and toluene. 
In each age group, telomeres were shorter for traffic police officers than for office 
workers. Consistently, telomeres measured in lymphocytes of coke-oven workers were 
significantly shorter than the control subjects, as exposure to polycyclic aromatic 
hydrocarbons can damage DNA and cause genetic instability (77). In this case, telomere 
shortening did not correlate with subjects’ age but with the number of years the workers 
had been exposed to damaging agents. 
4.3.4. Stress 
Glucocorticoid hormones are released by the adrenal gland because of stress, which 
reduce the levels of antioxidant molecules (78) and accelerates the loss of telomeric 
sequences (79). Women exposed to stress in their daily life showed higher oxidative 
pressure, less telomerase activity and shorter telomeres in peripheral blood 
mononuclear cells in comparison to women in the control group (80). More importantly, 
the difference in telomere length in these two groups was comparable to 10 years of 
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life. Therefore, women with elevated stress levels had more risk to suffer early age-
related diseases. 
The effect of stress on telomeres can also be seen in new-borns as their telomere length 
is shorter depending on the stress levels that the mother experienced during her 
pregnancy (81). 
4.3.5. Diet 
A study carried out in a group of women showed that dietary intake of polyunsaturated 
fatty acids is negatively associated with telomere length, while a dietary intake of fibre 
correlates positively (82). An increase in longevity has also been seen with a reduction 
in protein intake, as a reduction in the protein content by 40% in rats causes a 15% 
increase in their lifespans (83,84). 
As outlined above, oxidative stress leads to telomere shortening, so the dietary intake 
of antioxidants will reduce the rate of telomere loss. This was demonstrated in a study 
where a group of subjects took antioxidant omega-3 fatty acids, and their rate of 
telomere shortening was lower compared to the control group (85). 
Moreover, not only what we eat can affect telomere length but also the quantity of food 
we consume. Dietary restriction in animals has shown to reduce oxidative burden, DNA 
damage and reduce growth rate (83). Animals were kept in a biologically younger state 
and their lifespan was increased by up to 66% (83). 
4.3.6. Exercise 
Physical activity, together with a healthy diet, is recommended to have a better health 
as it reduces fat and fastens elimination of waste products. It turns into a reduced 
oxidative stress and preventing deterioration of telomeres. 
Exercise was shown to be associated with high telomerase activity and repression of 
some apoptosis proteins such as p53 and p16 in mice (86). Furthermore, leukocytes from 
athletes had more telomerase activity in comparison to non-athletes (86). 
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5. CONCLUSIONS AND DISCUSSION 
Telomeres are a small but very important part of DNA as they are responsible for keeping 
the integrity of the genome of all living organisms. In case of mammals, telomerase is 
essential to solve the end-replication problem and to maintain telomere length for 
specie reproduction. Specifically, in humans, telomeres and telomerase have complex 
structures and this enzyme is well regulated and controlled. 
Both cell and physical aging that can be observed on the surface are caused by telomere 
shortening, and this also limits individual lifespan. 
Different genetic mutations in genes associated with telomeres and telomerase can 
cause unavoidable illnesses such as dyskeratosis congenital. Howbeit, cells have 
mechanisms to prevent DNA from damage despite not having genetic problem, such as 
senescence or apoptosis, but when telomeres are not long enough we are still more 
prone to suffer diseases as diabetes and cardiovascular diseases, among others. 
Moreover, when a cell escapes from mortality stage 2 (M2), telomerase can be activated 
and the cell becomes immortal, possibly leading to cancer. 
Various anticancer therapies targeting telomerase are being studied, and also other 
therapies where telomerase activity is stimulated, although the latter has a high risk of 
developing undesirable tumours. Much research has to be done yet, but it is clear that 
this a field with great interest and possibilities for therapy. 
However, since there are many external factors that can accelerate telomere loss, it is 
in everybody’s hands to have a healthy lifestyle. Exercising, eating healthy and less 
quantity, not smoking and reducing stress can contribute to reduce telomere shortening 
and thus avoid premature aging or age-related diseases. 
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